Effect of point application therapy for bronchial asthma: a multicenter randomized controlled trial.

PubMed 2026 Open access

Read full text
Authors: Huanfang Xu, Jiashan Li, Li Yang, Wenzhong WU, Jun Yang, Wei Emma Zhang, Hui Ling Li, Nini QU, Rui Wang, Landi Wang, Hongzhi YANG, Lihua ZHANG
+4 more Yong HE, Guanyu Xiong, Baoyan LIU, YiGong Fang
DOI: 10.19852/j.cnki.jtcm.2026.01.018
Cited by: 1

Abstract

OBJECTIVE: To assess the efficacy of point application therapy (PAT) in alleviating the exacerbation of chronic respiratory diseases represented by bronchial asthma. METHODS: /FVC), and use of palliative drugs during bronchial asthma exacerbations at 12 and 24 months. The adverse events (AEs) were also assessed. RESULTS: %pred at 12 months. Treatment-related AEs were mild and more common in the PAT group than in the placebo PAT group. No serious AEs were reported. CONCLUSION: PAT conducted on dog days could reduce asthma exacerbations in patients with bronchial asthma.

Fields of Study & Subjects

Asthma and respiratory diseases Acupuncture Treatment Research Studies Inhalation and Respiratory Drug Delivery

Publication details

Journal / source
PubMed
Volume
46
Issue
1
Pages
195–204
Publication date
1 February 2026
Language
EN